Cerebral palsy. Cerebral palsy
Conditions
Interventions
Intervention group: For patients with cerebral palsy, first 500 units of botulinum toxin type A (Botox®, Masport, Iran) is diluted with 3 ml of normal saline. The child is placed in the supine positio
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 16 Years
Inclusion criteria
Inclusion criteria: Affliction cerebral palsy Drooling score more than 4
Exclusion criteria
Exclusion criteria: Contraindications for injection of Botulinum toxin A Botulinum toxin type A injection in three month ago Perform recent maxillofacial surgery that may interfere with saliva production and flow Receive systemic medication to treat sialorrhea in the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The amount and intensity of saliva secretion based on drooling frequency and severity score. Timepoint: drooling frequency and severity Score before injection, 2 weeks after injection, one month, 2 months, 4 months and 6 months after injection. Method of measurement: drooling frequency and severity Score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score related to salivation based on a questionnaire. Timepoint: Before injection, 2 weeks after injection, one month, 2 months, 4 months and 6 months after injection. Method of measurement: Teacher drooling scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadeseh Ghasemi
Esfahan University of Medical Sciences
Outcome results
None listed